Notice: This company has been marked as potentially delisted and may not be actively trading. Phoenix Biotech Acquisition (PBAX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationFebruary 14, 2024 | businesswire.comTrading was temporarily halted for "PBAX" at 12:02 PM with a stated reason of "LULD pause." Trading set to resume at 12:02 PM. February 13, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 03:02 PM with a stated reason of "LULD pause." Trading set to resume at 04:02 PM. February 12, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 12:02 PM with a stated reason of "LULD pause."February 12, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 10:02 AM with a stated reason of "LULD pause."February 12, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 02:02 PM with a stated reason of "LULD pause."February 9, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 02:02 PM with a stated reason of "LULD pause."February 7, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 6, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 09:02 AM with a stated reason of "LULD pause."February 6, 2024 | marketbeat.comPhoenix Biotech Acquisition (NASDAQ:PBAX) Shares Up 0.7%Phoenix Biotech Acquisition (NASDAQ:PBAX) Trading Up 0.7%February 3, 2024 | marketbeat.comTrading was temporarily halted for "PBAX" at 07:06 AM with a stated reason of "News pending."June 5, 2023 | marketbeat.comOLD Mission Capital LLC Takes $106,000 Position in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX)OLD Mission Capital LLC purchased a new stake in shares of Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX - Get Rating) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 10,456 shares of the company's stock, valued at approximately $106,March 2, 2023 | marketbeat.com Get Phoenix Biotech Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PBAX and its competitors with MarketBeat's FREE daily newsletter. Email Address PBAX Media Mentions By Week PBAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBAX News Sentiment▼0.001.36▲Average Unclassified News Sentiment PBAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBAX Articles This Week▼00▲PBAX Articles Average Week Get Phoenix Biotech Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PBAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cantor Equity Partners, Inc. Class A Ordinary Shares News ESH Acquisition News Marblegate Acquisition News Patria Latin American Opportunity Acquisition News Plum Acquisition Corp. III News Spring Valley Acquisition Corp. II News SilverBox Engaged Merger Corp I News Papaya Growth Opportunity Corp. I News Aimei Health Technology News Concord Acquisition Corp II News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBAX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phoenix Biotech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phoenix Biotech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
